The association between patient- and procedure-related factors and patient-reported intraprocedural pain during fluoroscopically guided lumbar epidural injections: A real-world cohort study Authors: Andrew R Stephens, Hasan S Sen, Timothy M Curtis, Ali Arafat, Austin Le, Campbell Miller, Amanda N Cooper, Zachary L McCormick, Aaron Conger, Daniel M Cushman Published: 2026 ABSTRACT AbstractBackgroundFluoroscopically guided lumbar epidural steroid injections (ESIs) are commonly performed to treat lumbar radicular pain. Intraprocedural pain is an important patient centered aspect of the procedural experience and may influence satisfaction, anxiety, and willingness to undergo repeat interventions. Although prior studies have suggested that interlaminar approaches may be less painful than transforaminal injections, the patient and procedure related factors associated with intraprocedural pain in routine clinical practice remain incompletely characterized.Objective1. To evaluate the association between patient- and procedure-related factors and intraprocedural pain during lumbar epidural steroid injections. 2. To compare intraprocedural pain between lumbar transforaminal epidural steroid injections (LTFESI), lumbar interlaminar epidural steroid injections (LIESI) and caudal epidural steroid injections.MethodsThis single-center observational cohort study analyzed consecutive adult patients who underwent fluoroscopically guided LTFESI, LIESI or caudal injections between February 2022 and June 2022. Pain scores were collected immediately before and after the procedure, with intraprocedural pain assessed using immediate recall. Scores were obtained by non-physician staff while the performing physician was not present. Demographic variables including age, sex, and body mass index were obtained through electronic medical record review. Multivariable linear regression analyses were performed to evaluate associations between patient- and procedure-related factors and intraprocedural pain scores.ResultsA total of 582 injections were performed. The mean intraprocedural pain score was 4.57 ± 2.79 on a 0 to 10 numeric rating scale. Increasing age was significantly associated with lower intraprocedural pain scores (β = −0.029; 95% CI −0.043 to −0.014; p < 0.001), while male sex was associated with lower reported pain compared with female sex (β = −0.59; 95% CI −1.05 to −0.12; p = 0.013). Higher pre-procedure pain (β = 0.24; 95% CI 0.14 to 0.34; p < 0.001) and greater injectate volume (β = 0.45; 95% CI 0.12 to 0.77; p = 0.007) were independently associated with higher intraprocedural pain after adjustment for injection approach and other covariates. In contrast, injection approach (LTFESI vs. LIESI vs. caudal ESI) itself was not associated with intraprocedural pain.ConclusionIn this real-world cohort, younger age, female sex, higher pre-procedure pain and higher injectate volume were associated with increased intraprocedural pain during fluoroscopically-guided lumbar ESIs. There were no differences in intraprocedural pain scores between LTFESI, LIESI, and caudal injections. These findings highlight the importance of considering patient-specific demographic factors when counseling patients and optimizing strategies to improve procedural comfort.Keywords: Patient demographics, Intraprocedural pain, Fluoroscopically guided procedures, Lumbar TFESI, Lumbar interlaminar injections, Caudal injections Introduction Fluoroscopically-guided lumbar epidural steroid injections (ESIs) are routinely performed to treat lumbar radicular pain. The utilization of these procedures has increased substantially over recent decades, reflecting their central role in contemporary interventional pain practice [1]. Prior literature has demonstrated that lumbar transforaminal epidural steroid injections (LTFESI) can provide significant improvements in pain and function [2]. Although some evidence suggests lumbar interlaminar epidural steroid injection (LIESI) and caudal injections may be less effective than transforaminal epidural steroid injections, they have clinical utility [3,4]. During interventional procedures, patients commonly report a reproduction of their radicular pain [5,6]. Prior literature is mixed as to whether provocation of symptoms is correlated with short- or long-term outcomes [[7], [8], [9]]. Prior work has evaluated factors that are related to increased intraprocedural pain for musculoskeletal procedures and have primarily focused on procedural factors including procedure type, injection location, depth of needle placement, needle diameter, injectate characteristics, and injection velocity [[10], [11], [12], [13], [14], [15], [16], [17], [18]]. More clarity in how these procedural factors impact intraprocedural pain with lumbar ESI is needed. Other studies have demonstrated that patient demographic characteristics such as sex, age, body mass index (BMI) and mental health are associated with generalized pain sensitivity and pain perception across a variety of clinical settings [[18], [19], [20], [21], [22]]. In contrast, relatively little is known about how these patient-specific demographic factors relate to pain experienced during fluoroscopically-guided lumbar ESI procedures themselves. Additionally, there is a lack of literature comparing intraprocedural pain between LTFESI, LIESI and caudal injections. Procedural pain is an important patient-centered outcome, as it directly influences the procedural experience and may affect patient satisfaction, anxiety, and willingness to undergo future interventions. The aim of this study was to evaluate the association between patient- and procedure-related factors and procedural pain reported during fluoroscopically guided lumbar ESI and to compare intraprocedural pain between LTFESI, LIESI, and caudal steroid injections. Methods Study design This was a single-center observational cohort study approved by the institutional review board at the senior authors’ institution (IRB #69703). Patient-reported pain outcomes were collected using immediate recall during routine clinical care for fluoroscopically-guided LTFESI, LIESI, and caudal ESIs performed between February 2022 and June 2022. Pre- and post-procedure pain scores utilizing an 11-point numeric rating scale (NRS) were obtained before and after the procedure, respectively, while patients were also asked to rate their intraprocedural pain using NRS directly following the completion of the procedure using immediate recall. The pain scores were obtained by non-physician staff while the performing physician was not present. Demographic and procedural variables were obtained through retrospective electronic medical record review for the study analysis. Patient population Adult patients aged 18 years or older who underwent a fluoroscopically-guided LTFESI, LIESI, or caudal ESI at a tertiary academic interventional spine and musculoskeletal medicine clinic were eligible for inclusion. Patients were excluded if they were unable to reliably report pain scores due to limited English proficiency without access to a certified medical interpreter, aphasia, cognitive impairment, or other communication limitations. Patients who received moderate sedation during the procedure were also excluded from analysis. Physicians and procedures Procedures were performed by fellowship-trained physicians in interventional spine and musculoskeletal medicine, pain medicine, or sports medicine or these physicians directly supervised residents/fellows who performed the procedure. All procedures were performed under fluoroscopic guidance in accordance with established technical standards and recommendations from the International Pain and Spine Intervention Society (IPSIS) [23]. Procedure type was selected and performed at the discretion of the treating physician. Data collection Pain intensity was assessed using a numeric rating scale ranging from 0 to 10, where 0 indicated no pain and 10 indicated the worst pain imaginable. The intraprocedural pain score reflected patient recall of pain experienced during the procedure. Patients were not instructed in advance to anticipate or track procedural pain. Patients were asked, “how painful was your procedure, on a scale of zero (no pain whatsoever) to ten (worst pain imaginable)?” Interpretation of what consisted of the procedure was left to the individual patient. Demographic and clinical variables extracted from the medical record included age, sex, BMI, and race. Procedural variables included procedure type, local anesthetic and injectate characteristics, needle size and number, use of sodium bicarbonate, fluoroscopy time (surrogate for procedure length) and presence or absence of a trainee during the procedure. All procedural data were extracted from the performing physician's procedure documentation. Statistical analysis Patient demographic and procedural characteristics were summarized using descriptive statistics, with continuous variables reported as means with standard deviations and categorical variables reported as frequencies with percentages. Statistical significance was defined using a two-sided alpha level of 0.05. Multivariable linear regression analysis was performed to assess the correlation of variables with higher intraprocedural pain. Additionally, a second multivariable analysis was performed to assess the correlation of variables with immediate post-procedure pain scores. Covariates included age, sex, BMI, race, presence of trainee, injectate type and volume, anesthetic type, needle gauge, needle length, fluoroscopy time, laterality, use of sodium bicarbonate, and pre-procedure pain score. Post-procedure pain was excluded to avoid post-exposure adjustment. Categorical variables were modeled using indicator terms with LTFESI as the reference injection type. Procedures with missing covariate data were excluded using listwise deletion. Results A total of 582 fluoroscopically-guided lumbar epidural injections were performed during the study time frame. There were a total of 466 LTFESI, 68 LIESI, and 48 caudal ESIs. Patients had a mean age of 60.0 ± 16.1 years, and 52.7% of injections were performed in female patients. Additional demographic characteristics are presented in Table 1. Table 1Baseline patient demographic and procedural characteristics.Table 1VariableValueAge59.96 (16.09)BMI30.30 (7.24)Pre-procedure pain5.11 (2.38)Intra-procedure pain4.57 (2.79)Post-procedure pain1.72 (2.31)Sex: F307 (52.7%)Sex: M275 (47.3%)Race: Caucasian503 (86.4%)Race: Other79 (13.6%)Lumbar TFESI466 (80.1%)Lumbar interlaminar68 (11.7%)Caudal48 (8.2%)Injectate type: Dexamethasone460 (79.0%)Injectate type: Triamcinolone95 (16.3%)Injectate type: Methylprednisolone23 (4.0%)Injectate type: Unknown4 (0.7%)Injectate anesthetic type: Lidocaine554 (95.2%)Injectate anesthetic type: Bupivacaine28 (4.8%)Unilateral432 (74.2%)Bilateral150 (25.8%)No Trainee385 (66.2%)Fellow161 (27.7%)Resident36 (6.2%)Fluoroscopy Time33.9 (18.8)Needle Gauge: 1855 (9.5%)Needle Gauge: 2029 (5.0%)Needle Gauge: 22406 (70.0%)Needle Gauge: 2592 (15.8%)Bicarbonate Used281 (48.3%)*Continuous variables are reported as mean (Standard Deviation).*Categorical variables are reported as N (%). Baseline patient demographic and procedural characteristics. *Continuous variables are reported as mean (Standard Deviation). *Categorical variables are reported as N (%). Mean patient-reported pain scores were 5.11 ± 2.38 prior to the procedure, 4.57 ± 2.79 for pain during the procedure, and 1.72 ± 2.31 following the procedure. Intra-procedural pain In multivariable linear regression analysis of variables related to intraprocedural pain, with LTFESI as the reference group, neither LIESI nor caudal ESIs were associated with significantly different intraprocedural pain. Increasing age was associated with lower intraprocedural pain scores (β = −0.029; 95% CI −0.043 to −0.014; p < 0.001). Male sex was also associated with lower reported intraprocedural pain compared with female sex (β = −0.59; 95% CI −1.05 to −0.12; p = 0.013). In contrast, higher pre-procedure pain was associated with higher intraprocedural pain scores (β = 0.24; 95% CI 0.14 to 0.34; p < 0.001). Greater injectate volume was also associated with higher intraprocedural pain scores (β = 0.45; 95% CI 0.12 to 0.77; p = 0.007). Longer fluoroscopy times were not significantly associated with intraprocedural pain (β = 0.015; 95% CI 0.000 to 0.030; p = 0.051). Regression coefficients and corresponding confidence intervals for all demographic and procedural predictors are presented in Table 2. Table 2Linear regression analysis of patient demographic predictors of intraprocedural pain.Table 2VariableAdjusted β95% CIp-valueInjection Type (ref = Lumbar transforaminal epidural steroid injection)Caudal−0.9−4.24 to 2.430.595Lumbar interlaminar0.9−2.65 to 4.450.620 Patient FactorsAge (per year)−0.029−0.043 to −0.014<0.001Male sex−0.586−1.049 to −0.1230.013BMI0.012−0.021 to 0.0450.478Race (Other vs White)0.132−0.519 to 0.7830.690Pre-procedure pain0.2410.143 to 0.339<0.001 Procedural FactorsInjectate volume (mL)0.4470.122 to 0.7730.007Injectate dose (mg)−0.078−0.170 to 0.0140.095Steroid: Methylprednisone vs Dexamethasone4.83−0.64 to 10.300.084Steroid: Triamcinolone vs Dexamethasone4.26−1.46 to 9.980.143Anesthetic: Lidocaine vs Bupivacaine−1.39−3.85 to 1.070.265Needle gauge: 18 vs 250.02−2.66 to 2.690.991Needle gauge: 20 vs 25−0.28−2.70 to 2.140.820Needle gauge: 21 vs 25−0.72−6.40 to 4.950.803Needle gauge: 22 vs 250.69−0.24 to 1.610.144Needle length (in)−0.058−0.506 to 0.3900.799Fluoroscopy time (s)0.015−0.000 to 0.0300.051Bilateral (Yes vs No)0.103−0.452 to 0.6570.716Trainee present vs none0.25−0.292 to 0.7910.365Sodium Bicarbonate (Yes vs No)−0.254−1.33 to 0.820.643*Bolded P values denote significance. Linear regression analysis of patient demographic predictors of intraprocedural pain. *Bolded P values denote significance. Post-procedural pain Multivariable linear regression analysis demonstrated that male sex (β = 0.4; 95% CI 0.02 to 0.78; p = 0.037), higher pre-procedure pain (β = 0.25; 95% CI 0.17 to 0.33; p < 0.001), and higher intraprocedural pain (β = 0.21; 95% CI 0.14 to 0.28; p < 0.001) were all associated with higher post-procedure pain scores. Increasing patient age (β = −0.013; 95% CI -0.03 to −0.002; p = 0.026) and performance of a bilateral procedure (β = −0.55; 95% CI -0.99 to −0.09; p = 0.017) were both associated with lower post-procedure pain scores. There was no statistically significant difference in post-procedural pain between LTFESI, LIESI and caudal ESI (Table 3). Table 3Multivariable linear regression for post-procedure pain.Table 3VariableAdjusted β95% CIp-valueInjection TypeCaudal vs LTFESI−0.85−3.54 to 1.840.535LIESI vs LTFESI−0.17−3.03 to 2.700.909Patient FactorsAge (per year)−0.0135−0.025 to −0.0020.026Male sex0.40.024 to 0.7770.037BMI0.0069−0.020 to 0.0340.616Race (Other vs Caucasian)−0.027−0.552 to 0.4990.921Pre-procedure pain0.2480.168 to 0.329<0.001Intra-procedure pain0.210.141 to 0.280<0.001 Procedural FactorsTrainee present vs none−0.157−0.594 to 0.2810.482Injectate volume (mL)0.067−0.197 to 0.3320.617Injectate dose (mg)0.008−0.067 to 0.0820.843Fluoroscopy time (s)−0.001−0.013 to 0.0110.872Needle length (in)−0.116−0.478 to 0.2450.527Bilateral (Yes vs No)−0.545−0.993 to −0.0970.017Needle gauge 18 vs 25−0.25−2.404 to 1.9050.820Needle gauge 20 vs 251.296−0.655 to 3.2470.192Needle gauge 21 vs 25−1.937−6.516 to 2.6430.406Needle gauge 22 vs 250.411−0.333 to 1.1550.278*Bolded P values denote significance. Multivariable linear regression for post-procedure pain. *Bolded P values denote significance. Discussion This study demonstrated that younger age, female sex, higher pre-procedure pain scores, and greater injectate volume were associated with higher intraprocedural pain scores. These findings indicate that patient-specific demographic factors were associated with the procedural pain experience during fluoroscopically-guided lumbar epidural spine injections. Patient related factors In this study, male sex was associated with lower reported intraprocedural pain compared with female sex. This finding is consistent with prior work demonstrating a higher likelihood of women reporting increased pain across a variety of clinical and experimental pain paradigms [19]. A systematic review by Racine et al. showed that sex-related differences in pain perception are heterogeneous and may depend on the type of pain stimulus, with minimal differences observed for muscle, pressure, or electrical pain [24]. In addition to potential biological differences, psychosocial and societal factors may influence pain reporting, with women potentially more likely to acknowledge and report pain than men [25]. Although male sex was associated with lower intraprocedural pain, it was associated with higher post-procedural pain. Increasing age was associated with lower reported intraprocedural and post-procedural pain. This observation is consistent with findings from Ostrom et al., who reported reduced pain sensitivity with advancing age [20]. Age-related changes in sensory processing, including decreased peripheral receptor density and altered nociceptive signaling, may partially reflect this association [26]. Additionally, older patients have been shown to report higher satisfaction with medical care across musculoskeletal and spine related settings, which may influence pain perception or reporting behavior [[27], [28], [29], [30]]. Contrary to our findings, a recent study by Smuek et al. found that greater age was associated with higher procedure pain. Their study evaluated a combination of LTFESI, facet joint injections and sacroiliac joint injections [31], which may explain differences in their findings. In this study, BMI did not significantly correlate with increased intraprocedural pain. This differs from prior studies demonstrating greater overall pain severity among individuals with elevated BMI [20] but is consistent with Smuek et al.’s findings [31]. Although prior studies have demonstrated that higher BMI is associated with longer procedure times and increased fluoroscopy exposure across multiple interventional spine procedures [32,33], it did not seem to correlate with a greater degree of pain experienced during the injection. Although not statistically significant, fluoroscopy time approached statistical significance, suggesting that procedural duration may warrant further evaluation in larger cohorts. Procedure related factors This work demonstrated that the majority of technical aspects of the procedure did not significantly impact intraprocedural pain. Needle gauge was not associated with increased pain during the procedure, but this may be confounded by the fact that local anesthetic is routinely injected along the needle track during the procedure. Greater injectate volume, however, was associated with higher procedural pain. This finding is intuitive, as injectate delivery is commonly perceived as a painful component of these procedures but differs from Faust et al. who demonstrated an inverse correlation of procedural pain with injectate volume for musculoskeletal injections. This difference is likely due to the fact that a main driver of larger injectate volumes for fluoroscopic injections is the amount of contrast injected. This is performed prior to anesthetic administration. In musculoskeletal injections anesthetic is often the first thing administered whether with or without steroids. Larger volumes would likely indicate a greater amount of anesthetic given during the injection, perhaps lowering the intraprocedural pain. In our study, performing a bilateral procedure did not significantly correlate with intraprocedural pain scores but was associated with lower post-procedural scores. Comparison of lumbar epidural administration approaches There was no difference in intraprocedural pain between LTFESI, LIESI or caudal ESI. This differs from Perdecioğlu et al. who found that patients undergoing LIESI reported significantly higher rates of comfort during the procedure [34]. There appears to be higher-quality evidence supporting the effectiveness of LTFESI compared with LIESI or caudal ESI, although many studies report no significant differences in clinical outcomes [[35], [36], [37], [38], [39]]. Limitations This study has several limitations. The observational design introduces the potential for selection bias, and although all procedures were performed in accordance with IPSIS technical standards, subtle differences in technique between performing physicians may have been present and reflect real-world variation. Intraprocedural pain was self-reported by patients and recorded by clinical staff, which may introduce reporting variability and recall bias. Analyses were conducted at the procedure level, and within-patient correlation was not explicitly modeled. As a result, standard errors may be underestimated and observed associations should be interpreted as exploratory rather than confirmatory. In addition, this study did not evaluate whether intraprocedural pain is associated with differences in short- or long-term procedural effectiveness. Although patient-specific factors were associated with higher intraprocedural pain, prior literature has not demonstrated a consistent relationship between procedural pain and clinical outcomes [[7], [8], [9]]. This study was performed at a single institution, which may reflect regional differences and operator preferences. Residual confounding from unmeasured procedural or psychosocial factors may also be present given the low R2 value of the multivariable analysis model. Conclusion The present study demonstrated that younger age, female sex, and higher pre-procedure pain were associated with higher patient-reported intraprocedural pain during fluoroscopically-guided LTFESI, LIESI, or caudal ESI. There was no difference in intraprocedural pain between the injection approaches. These findings highlight the importance of considering patient-level factors when counseling patients, setting expectations, and developing strategies to optimize procedural comfort in clinical practice. Funding None. Conflict of interest statement Zachary L. McCormick, MD serves on the Board of Directors of the International Pain and Spine Intervention Society (IPSIS), has research grants from Avanos Medical, Boston Scientific, DiscGenics Presidio Medical, Saol Therapeutics, Spine Biopharma, SPR Therapeutics, Stratus Medical (paid directly to the University of Utah), and previous consultancies with Avanos Medical, Saol Therapeutics, Stryker, and OrthoSon (all relationships ended). Aaron Conger, DO received research grant funding from Stratus Medical (paid directly to the University of Utah). References